BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30368130)

  • 1. Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.
    Elie BT; Fernández-Gallardo J; Curado N; Cornejo MA; Ramos JW; Contel M
    Eur J Med Chem; 2019 Jan; 161():310-322. PubMed ID: 30368130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Titanocene-Gold Compounds Based on Highly Active Gold(I)-N-Heterocyclic Carbene Anticancer Agents: Preliminary in vitro Studies in Renal and Prostate Cancer Cell Lines.
    Curado N; Giménez N; Miachin K; Aliaga-Lavrijsen M; Cornejo MA; Jarzecki AA; Contel M
    ChemMedChem; 2019 Jun; 14(11):1086-1095. PubMed ID: 30924298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.
    Elie BT; Pechenyy Y; Uddin F; Contel M
    J Biol Inorg Chem; 2018 May; 23(3):399-411. PubMed ID: 29508136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterometallic titanium-gold complexes inhibit renal cancer cells
    Fernández-Gallardo J; Elie BT; Sadhukha T; Prabha S; Sanaú M; Rotenberg SA; Ramos JW; Contel M
    Chem Sci; 2015 Sep; 6(9):5269-5283. PubMed ID: 27213034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auranofin-Based Analogues Are Effective Against Clear Cell Renal Carcinoma
    Elie BT; Hubbard K; Layek B; Yang WS; Prabha S; Ramos JW; Contel M
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):644-654. PubMed ID: 32832867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.
    Mui YF; Fernández-Gallardo J; Elie BT; Gubran A; Maluenda I; Sanaú M; Navarro O; Contel M
    Organometallics; 2016 May; 35(9):1218-1227. PubMed ID: 27182101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
    J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.
    González-Pantoja JF; Stern M; Jarzecki AA; Royo E; Robles-Escajeda E; Varela-Ramírez A; Aguilera RJ; Contel M
    Inorg Chem; 2011 Nov; 50(21):11099-110. PubMed ID: 21958150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
    Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
    Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K; Bao Y; Liu F; Xiao C; Li K; Zhang C; Huang R; Lin J; Zhang J; Jin Y
    Eur J Med Chem; 2019 Oct; 179():805-827. PubMed ID: 31295714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthalimide gold(I) phosphine complexes as anticancer metallodrugs.
    Bagowski CP; You Y; Scheffler H; Vlecken DH; Schmitz DJ; Ott I
    Dalton Trans; 2009 Dec; (48):10799-805. PubMed ID: 20023909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
    Rodić MV; Leovac VM; Jovanović LS; Spasojević V; Joksović MD; Stanojković T; Matić IZ; Vojinović-Ješić LS; Marković V
    Eur J Med Chem; 2016 Jun; 115():75-81. PubMed ID: 27084495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo design of thioredoxin reductase-targeted heterometallic titanocene-gold compounds of chlorambucil for mechanistic insights into renal cancer.
    Tabrizi L; Olasunkanmi LO; Fadare OA
    Chem Commun (Camb); 2019 Dec; 56(2):297-300. PubMed ID: 31808475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolato gold(I) complexes containing water-soluble phosphane ligands: a characterization of their chemical and biological properties.
    Vergara E; Cerrada E; Clavel C; Casini A; Laguna M
    Dalton Trans; 2011 Nov; 40(41):10927-35. PubMed ID: 21904768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
    Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
    Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoactivated in Vitro Anticancer Activity of Rhenium(I) Tricarbonyl Complexes Bearing Water-Soluble Phosphines.
    Marker SC; MacMillan SN; Zipfel WR; Li Z; Ford PC; Wilson JJ
    Inorg Chem; 2018 Feb; 57(3):1311-1331. PubMed ID: 29323880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
    García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
    J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Macrocyclic Ruthenium(III) Complex Inhibits Angiogenesis with Down-Regulation of Vascular Endothelial Growth Factor Receptor-2 and Suppresses Tumor Growth In Vivo.
    Kwong WL; Lam KY; Lok CN; Lai YT; Lee PY; Che CM
    Angew Chem Int Ed Engl; 2016 Oct; 55(43):13524-13528. PubMed ID: 27717148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
    Gandin V; Trenti A; Porchia M; Tisato F; Giorgetti M; Zanusso I; Trevisi L; Marzano C
    Metallomics; 2015 Nov; 7(11):1497-507. PubMed ID: 26190698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.